Form 8-K - Current report:
SEC Accession No. 0001493152-25-007097
Filing Date
2025-02-18
Accepted
2025-02-18 08:45:24
Documents
14
Period of Report
2025-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51310
  Complete submission text file 0001493152-25-007097.txt   272874

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE celu-20250212.xsd EX-101.SCH 3892
3 XBRL DEFINITION FILE celu-20250212_def.xml EX-101.DEF 26799
4 XBRL LABEL FILE celu-20250212_lab.xml EX-101.LAB 37063
5 XBRL PRESENTATION FILE celu-20250212_pre.xml EX-101.PRE 25423
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6064
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 25632913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)